Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,474 | 212 | 95.9% |
| Consulting Fee | $150.00 | 1 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $652.96 | 47 | $0 (2024) |
| Amgen Inc. | $435.61 | 19 | $0 (2024) |
| ABBVIE INC. | $266.37 | 30 | $0 (2024) |
| Novo Nordisk Inc | $230.85 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $214.10 | 11 | $0 (2024) |
| PFIZER INC. | $172.59 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $166.81 | 10 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $164.85 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $164.41 | 11 | $0 (2024) |
| Lilly USA, LLC | $153.41 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $767.75 | 34 | Novo Nordisk Inc ($105.78) |
| 2023 | $223.18 | 10 | Amgen Inc. ($73.75) |
| 2022 | $791.90 | 43 | Merck Sharp & Dohme LLC ($214.91) |
| 2021 | $731.17 | 56 | AbbVie Inc. ($221.24) |
| 2020 | $494.50 | 27 | AstraZeneca Pharmaceuticals LP ($109.69) |
| 2019 | $157.43 | 11 | Janssen Pharmaceuticals, Inc ($38.44) |
| 2018 | $332.98 | 22 | COMSORT, Inc ($150.00) |
| 2017 | $125.37 | 10 | Novo Nordisk Inc ($40.44) |
All Payment Transactions
213 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.41 | General |
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Obesity | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Obesity | ||||||
| 09/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: VACCINE | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: VACCINE | ||||||
| 05/19/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Inflammation | ||||||
| 04/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Obesity | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: VACCINE | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Respiratory | ||||||
| 04/07/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,012 | 2,926 | $581,275 | $141,121 |
| 2022 | 28 | 1,762 | 2,523 | $424,589 | $124,905 |
| 2021 | 26 | 1,578 | 2,178 | $352,205 | $111,747 |
| 2020 | 25 | 1,455 | 1,913 | $310,539 | $85,281 |
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 257 | 546 | $225,610 | $58,666 | 26.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 194 | 194 | $119,310 | $28,902 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 170 | $49,000 | $11,670 | 23.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 27 | 27 | $28,250 | $7,590 | 26.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 66 | 66 | $18,480 | $5,003 | 27.1% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 22 | 23 | $12,880 | $3,215 | 25.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $12,640 | $3,051 | 24.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 114 | 195 | $11,975 | $2,558 | 21.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 67 | 69 | $6,555 | $2,483 | 37.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 125 | 226 | $9,780 | $2,339 | 23.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 138 | 270 | $8,535 | $2,268 | 26.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 172 | 179 | $26,935 | $2,069 | 7.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 82 | 117 | $8,685 | $1,926 | 22.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 22 | $9,460 | $1,797 | 19.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 119 | 208 | $6,880 | $1,583 | 23.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 80 | 112 | $4,930 | $990.08 | 20.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 27 | 27 | $2,565 | $971.46 | 37.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 24 | 26 | $2,915 | $754.26 | 25.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 51 | 58 | $2,740 | $552.16 | 20.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 23 | 35 | $2,275 | $467.60 | 20.6% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 35 | 45 | $2,250 | $355.95 | 15.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 18 | 22 | $1,540 | $325.16 | 21.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 16 | 19 | $1,330 | $273.79 | 20.6% |
| 83550 | Iron binding capacity | Office | 2023 | 17 | 22 | $1,100 | $188.54 | 17.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 19 | 30 | $730.00 | $169.80 | 23.3% |
About Dr. Teresa Esposito, DO
Dr. Teresa Esposito, DO is a Family Medicine healthcare provider based in Massapequa, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1033265244.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Teresa Esposito, DO has received a total of $3,624 in payments from pharmaceutical and medical device companies, with $767.75 received in 2024. These payments were reported across 213 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,474).
As a Medicare-enrolled provider, Esposito has provided services to 6,807 Medicare beneficiaries, totaling 9,540 services with total Medicare billing of $463,055. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Massapequa, NY
- Active Since 01/28/2007
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1033265244
Products in Payments
- PNEUMOVAX 23 (Biological) $237.18
- JARDIANCE (Drug) $218.62
- Aimovig (Biological) $208.30
- BELSOMRA (Drug) $181.04
- Otezla (Drug) $156.83
- VRAYLAR (Drug) $148.65
- TRELEGY ELLIPTA (Drug) $125.83
- JANUVIA (Drug) $123.09
- UBRELVY (Drug) $120.56
- Dayvigo (Drug) $101.98
- NURTEC ODT (Drug) $95.70
- ENTRESTO (Drug) $92.39
- ELIQUIS (Drug) $92.28
- FARXIGA (Drug) $91.15
- Vascepa (Drug) $83.21
- LEQVIO (Drug) $72.02
- Repatha (Biological) $70.48
- Kerendia (Drug) $70.27
- GARDASIL (Biological) $66.66
- Wegovy (Drug) $64.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Massapequa
Stuart Horowitz, Do, DO
Family Medicine — Payments: $10,519
Jill Sisselman, D.o, D.O
Family Medicine — Payments: $7,137
Dr. Steven Golinowski, D.o, D.O
Family Medicine — Payments: $4,019
Richard Bebirian, Do, DO
Family Medicine — Payments: $2,792
Dr. Ching Yeh Lin, M.d, M.D
Family Medicine — Payments: $575.14
Dr. John Dimartino, Md, MD
Family Medicine — Payments: $45.02